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Objectives/Hypothesis: To determine if apnea-hypopnea index (AHI) and lowest oxygen saturation (LSAT) improve follow-
ing isolated supraglottoplasty for laryngomalacia with obstructive sleep apnea (OSA) in children.
Study Design: Systematic review and meta-analysis.
Methods: Nine databases, including PubMed/MEDLINE, were searched through September 30, 2015.
Results: A total of 517 studies were screened; 57 were reviewed; and 13 met criteria. One hundred thirty-eight patients
were included (age range: 1 month–12.6 years). Sixty-four patients had sleep exclusive laryngomalacia, and in these patients:
1) AHI decreased from a mean (M) 6 standard deviation (SD) of 14.0 6 16.5 (95% confidence interval [CI] 10.0, 18.0) to 3.3
6 4.0 (95% CI 2.4, 4.4) events/hour (relative reduction: 76.4% [95% CI 53.6, 106.4]); 2) LSAT improved from a M 6 SD of
84.8 6 8.4% (95% CI 82.8, 86.8) to 87.6 6 4.4% (95% CI 86.6, 88.8); 3) standardized mean differences (SMD) demonstrated
a small effect for LSAT and a large effect for AHI; and 4) cure (AHI < 1 event/hour) was 10.5% (19 patients with individual
data). Seventy-four patients had congenital laryngomalacia, and in these patients: 1) AHI decreased from a M 6 SD of 20.4 6
23.9 (95% CI 12.8, 28.0) to 4.0 6 4.5 (95% CI 2.6, 5.4) events/hour (relative reduction: 80.4% [95% CI 46.6, 107.4]); 2)
LSAT improved from a M 6 SD of 74.5 6 11.9% (95% CI 70.9, 78.1) to 88.4 6 6.6% (95% CI 86.4, 90.4); 3) SMD demon-
strated a large effect for both AHI and LSAT; and 4) cure was 26.5% (38 patients with individual data).
Conclusion: Supraglottoplasty has improved AHI and LSAT in children with OSA and either sleep exclusive laryngomala-
cia or congenital laryngomalacia; however, the majority of them are not cured.
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INTRODUCTION
Pediatric sleep disordered breathing is a common prob-
lem. An epidemiological systematic review and meta-analy-
sis1 estimated that the prevalence of pediatric snoring is
7.45% (95% confidence interval [CI], 5.75%–9.61% based on
parent observations) and that the prevalence of pediatric
obstructive sleep apnea (OSA) is 1% to 4%. Pediatric OSA
severity is classified as: no OSA: apnea-hypopnea index (AHI)
< 1; mild OSA: AHI 1 to < 5; moderate OSA: AHI 5 to < 10;
and severe: AHI  10 events/hour.2 In children, treatment
options include adenotonsillectomy,3 myofunctional therapy,4
palate expansion,5 and allergy management. The success
rate for adenotonsillectomy normalizing AHI (< 1 event/
hour) was found to be between 59.8% and 82.9% based on
two meta-analyses.3,6 There is a subset of children with OSA
who additionally have laryngomalacia (a disorder in which
supraglottic tissue collapses and subsequently obstructs nor-
mal airflow). The collapse of supraglottic structures can lead
to inspiratory stridor, which may get worse a few months
after birth.7 Triggers for stridor include upper respiratory
infections, feeding, crying, agitation, and the supine position.7
In traditional (congenital) laryngomalacia, patients
have symptoms during wakefulness and sleep; however,
some patients have supraglottic collapse only during sleep,
which we term sleep exclusive laryngomalacia. Typically,
patients with congenital laryngomalacia present early
given that there can be failure to thrive and significant
respiratory distress at times with cyanosis, retractions,
and/or witnessed apneic events.8 Sleep exclusive
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laryngomalacia has been described as occult laryngomala-
cia,2 late-onset laryngomalacia,9 state-dependent laryngo-
malacia,10 and sleep-dependent laryngomalacia.11 Sleep
exclusive laryngomalacia patients can present in older chil-
dren (2–18 years), has an estimated incidence of 3.9%, and
can be diagnosed with drug-induced sleep endoscopy.12
There have been studies reporting that supraglottoplasty
has successfully treated or even cured OSA in patients with
laryngomalacia; however, to our knowledge a systematic
review of the literature with meta-analysis has not been
performed. The primary objective was to determine
whether the AHI and lowest oxygen saturation (LSAT)
improve following isolated supraglottoplasty for both con-
genital and sleep exclusive laryngomalacia with obstructive
sleep apnea in children. To complete the objective, a system-
atic review of the international literature was performed for
polysomnography outcomes, as reported in children under-
going isolated supraglottoplasty as treatment for laryngo-
malacia with obstructive sleep apnea, and the data was
used to perform ameta-analysis.
MATERIALS AND METHODS
The Preferred Reporting Items for Systematic Reviews
and Meta-Analysis statement was followed as much as possible
during this study.13 As a systematic review of publically avail-
able articles, this study is exempted from institutional review
board review.
Search Strategy
Four authors (M.C., B.D., J.S., R.G.) each independently
searched initially on January 28, 2015, with an update through
September 30, 2015 in Google Scholar, PubMed, Scopus, Embase,
The Cochrane Library, Web of Science, Book Citation Index–Sci-
ence, Cumulative Index to Nursing and Allied Health and Confer-
ence Proceedings Citation Index–Science from the inception of
each database. Several terms, keywords, and phrases were
searched. A PubMed search strategy is: (((supraglot*) AND (slee*
OR snor* OR collapse OR apn* OR hypopn* OR oxygen)) OR
((supraglot* OR arytenoidectomy OR epiglottoplasty OR epiglot-
topexy OR Laryngomalacia/surgery* OR Glottis/surgery*) AND
(laryngomalacia))) OR ((“Laryngomalacia”[Mesh]) AND ((“Sleep
Apnea Syndromes”[Mesh]) OR sleep)).
Study Selection
Study inclusion criteria were as follows: 1) patients: children
(< 18 years [y]) who have either congenital or sleep exclusive lar-
yngomalacia and OSA; 2) intervention: isolated supraglottoplasty;
3) comparison: quantitative data pre- and postsupraglottoplasty;
4) outcome: polysomnography variables, general outcomes, and
complications; and 5) study design: all designs were included in
both published and unpublished forms and in all languages.
Exclusion criteria were 1) studies with additional surgeries per-
formed (unless individual patient data was reported for those
undergoing isolated supraglottoplasties), 2) studies with qualita-
tive outcomes only, and 3) patients with central sleep apnea.
Supraglottoplasty Surgeries
Based on the studies in this systematic review, the differ-
ent kinds of supraglottoplasty surgeries performed specifically
include: 1) unilateral aryepiglottic fold division, 2) bilateral
aryepiglottic fold division, 3) bilateral aryepiglottic fold division
with unilateral removal of redundant arytenoid tissue, and 4)
bilateral complete (bilateral aryepiglottic fold division and bilat-
eral removal of redundant arytenoid tissues). In some patients,
epiglottis surgery was also performed.
Study Quality Assessment
The National Institute for Health and Clinical Excellence
(NICE) quality assessment tool14 was used to assess the quality
of each individual study because it allows for assessment even
when studies are the same level of evidence.
Statistics
The null hypothesis was that there is no difference in pol-
ysomnography outcomes pre- and post-supraglottoplasty. The
IBM Statistical Package for Social Sciences software version
20.0 (Armonk, NY) was used for analyses. For two-tailed paired
t tests, a P value < 0.05 was considered statistically significant.
The Cochrane Collaboration’s Review Manager Software (REV-
MAN) version 5.3 was used for the meta-analysis. REVMAN
was used to calculate the mean differences (MD), standardized
mean differences (SMD), and 95% CI. Cohen’s guidelines15 were
used for interpreting the SMD magnitude of effect (absolute
value: small 5 0.2, medium 5 0.5, and large 5 0.8). Inconsis-
tency was evaluated with REVMAN’s I2 statistic, and the rec-
ommended cutoffs were followed (low inconsistency: 25%,
moderate inconsistency: 50%, and high inconsistency: 75%).16
Heterogeneity between studies was evaluated by the Cochran Q
statistic (Q statistic), and a P value  0.10 was considered to be
statistically significant heterogeneity.17 If inconsistency and/or
heterogeneity was present, REVMAN was used to perform a
sensitivity analysis by removing one study at a time until
inconsistency and/or heterogeneity no longer existed in order to
identify which studies were the sources. If AHI and respiratory
disturbance index (RDI) were reported in the study, the AHI
was selected for statistical analysis. If RDI alone was reported
in the study, the plan was to contact the authors to obtain the
AHI. As recommended by the Cochrane Collaboration, a funnel
plot assessment was performed if there were at least 10 studies
evaluating any given variable. For individual patient data suba-
nalyses, the standard pediatric OSA severity classification was
used: no OSA: AHI < 1, mild OSA: AHI 1 to < 5, moderate
OSA: AHI 5 to < 10, and severe: AHI  10 events/hour.2
Authors were contacted for studies that did not report enough
data for meta-analysis to determine whether additional patient
data could be obtained, which would allow inclusion in the
analysis.
RESULTS
The searches yielded 517 studies, which were
screened; 54 studies were reviewed in the full-text ver-
sion; and after reviewing the references, another three
studies were potentially relevant and were also reviewed
(57 total).2,7–12,18–66 Thirteen studies met criteria for
inclusion. Coauthor D.K.C. provided data from two stud-
ies (Chan (a) et al.20 and Chan (b) et al.2) that excluded
any duplicate patients and allowed for both studies to be
included in the meta-analysis. After review of all the
articles, only one article (Valera et al.60) reported the
RDI exclusively; the corresponding author was con-
tacted, and upon review of the raw data the AHI and
RDI were found to be the same. The corresponding
author for the study by Tholpady et al.59 was contacted
to confirm whether any of the patients undergoing
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supraglottoplasty also underwent tonsillectomy, and
the author replied that the patients did not; therefore,
the study data could be included in the meta-analysis.
Drs. Zafereo and Pereira confirmed that they always
divide the aryepiglottic folds bilaterally, and then in
60% of the children in this study performed the uni-
lateral supraglottoplasty, after that which consists of
unilateral excision of the cuneiform cartilages and
redundant mucosa. The corresponding author from
Digoy et al.23 was contacted twice in an attempt to
obtain individual patient data; however, the attempts
were unsuccessful. Figure 1 summarizes the study
selection.
Forty-four studies were excluded for the following rea-
sons: the number of patients undergoing polysomnography
pre- and postsupraglottoplasty was not provided43;
no quantitative data for polysomnograms was pro-
vided12,18,21,22,24–26,28,29,32–39,41,42,44–46,49,51,53,54,56,58,61,64,66;
only adults were included19; procedure(s) were performed
in addition to the supraglottoplasty with no stratification of
data for those who underwent isolated supraglott-
plasty27,50,63; only preoperative data was available55; some
children were sedated with choral hydrate47; the postoper-
ative data was only available for a fraction of patients30;
portable pulse-oximetry was used instead of formal
polysomnography31; or they were review articles.40,52,62
Overall, there were a total of 138 patients (ages 1
month–12.6 years) with quantitative polysomnographic
data who underwent isolated supraglottoplasty. Sixty-
four patients had sleep exclusive laryngomalacia, and 74
patients had congenital laryngomalacia.
Study Quality Assessment
Studies meeting criteria to be included in this
review were case reports, case series studies, or case-
control studies. The studies met three to six of the eight
NICE quality-assessment tool criteria (see Table I).
Sleep Exclusive Laryngomalacia
Apnea-Hypopnea Index. Polysomnography out-
comes for isolated supraglottoplasty demonstrated that
the AHI decreased from a mean (M) 6 standard deviation
(SD) of 14.0 6 16.5 (95% CI 10.0, 18.0) to 3.3 6 4.0 (95%
CI 2.4, 4.4) events/hour, see Table II. The MD was 10.7
events/hour (95% CI 214.9, 26.5). The relative reduction
of the mean values was 76.4% (95% CI 53.6, 106.4%). A
subanalysis using random effects modeling was performed
for four studies (62 patients) in which M 6 SD were
reported, and the AHI MD was 29.38 events/hour (95%
CI 212.67, 26.10), overall effect Z 5 5.60, P value <
0.00001, Q statistic P value 5 0.68 (no heterogeneity), I2
5 0% (no inconsistency). The AHI SMD was 20.99 (95%
CI 21.37, 20.62) (large magnitude of effect), overall effect
Z 5 5.17 P value < 0.00001, Q statistic P value 5 0.91 (no
heterogeneity), I25 0% (no inconsistency).
Lowest Oxygen Saturation. The overall mean pre-
and postsupraglottoplasty lowest oxygen saturation M 6
SD were 84.8% 6 8.4% (95% CI 82.8, 86.8) and 87.6% 6
4.4% (95% CI 86.6, 88.8) (see Table II). A subanalysis
with random effects modeling was performed for 62
patients in which M 6 SD were reported, the MD was
1.79 points (95% CI 20.37, 3.96), overall effect Z 5 1.62,
P value 5 0.10; Q statistic P value 0.29 (no heterogene-
ity) I2 5 19% (low inconsistency). The sensitivity analysis
demonstrated that after removal of the study by Chan (a)
et al. there was no heterogeneity (Q statistic P value 5
0.37) and no inconsistency (I2 5 0%). The LSAT SMD
was 0.40 (95% CI 0.04, 0.76) (small magnitude of effect),
overall effect Z 5 2.20 P value 0.03, Q statistic P value 5
0.65 (no heterogeneity), and I2 5 0% (no inconsistency).
Congenital Laryngomalacia
Apnea-Hypopnea Index. The AHI decreased from
an M 6 SD of 20.4 6 23.9 (95% CI 12.8, 28.0) to 4.0 6
4.5 (95% CI 2.6, 5.4) events/hour (38 patients) (see Table
III). The MD was 216.4 events/hour (95% CI 221.9,
Fig. 1. Flow diagram for studies report-
ing polysomnographic data for patients
undergoing isolated supraglottoplasty
for laryngomalacia with OSA.
N5 number of studies; OSA5 obstructive
sleep apnea; pts5 patients.
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210.9), and the relative reduction was 80.4% (95% CI
46.6, 107.4%). A subanalysis with random effects model-
ing was performed for the six studies (38 patients) in
which M 6 SD were reported, and the AHI MD was
28.78 events/hour (95% CI 212.40, 25.17), overall effect
Z 5 4.76, P value < 0.00001, Q statistic P value 5 0.19
(no heterogeneity), and I2 5 33% (low inconsistency).
The sensitivity analysis demonstrated that after removal
of the study by O’Connor et al.,48 there was no heteroge-
neity (Q statistic P value 5 0.89) and no inconsistency
(I2 5 0%). The AHI SMD was 21.21 (95% CI 21.83,
20.59) (large magnitude of effect), overall effect Z 5
3.84, P value 0.0001, Q statistic P value 5 0.91 (no het-
erogeneity), and I2 5 0% (no inconsistency).
Lowest Oxygen Saturation. The overall mean
pre- and postsupraglottoplasty lowest oxygen saturation
was reported for 41 patients. The LSAT M 6 SD were
74.5 6 11.9% (95% CI 70.9, 78.1) and 88.4 6 6.6% (95%
CI 86.4, 90.4) (see Table III). A subanalysis with random
effects modeling was performed for 41 patients in which
M 6 SD were reported: the MD was 12.18 points (95%
CI 4.02, 20.34), overall effect Z 5 2.93, P value 5 0.003;
Q statistic P value 0.006 (significant heterogeneity), and
I2 5 76% (high inconsistency). A sensitivity analysis
demonstrated that after removal of the data from the
study by Li et al.,67 there was no heterogeneity (Q statis-
tic P value 5 0.31) and low inconsistency (I2 5 16%).
The LSAT SMD was 1.31 (95% CI 0.32, 2.30) (large mag-
nitude of effect), overall effect Z 5 2.60, P value 0.009, Q
statistic P value 5 0.01 (significant heterogeneity), and
I2 5 73% (high inconsistency). The sensitivity analysis
demonstrated that after removal of the study by Li et al.
there was no heterogeneity (Q statistic P value 5 0.32)
and low inconsistency (I2 5 12%).
The overall MDs, SMDs with the magnitude of
effect based on Cohen’s guidelines for AHI and LSAT are
presented in Table IV.
Individual Patient Data Analysis
Nine studies 9–11,20,48,57,59,60,65 provided individual
patient data, whereas four studies did not.2,8,23,67 For
patients with sleep exclusive laryngomalacia, cure (AHI
< 1 event/hour) was observed in two out of 19 patients
(10.5%). For patients with congenital laryngomalacia,
cure was observed in 10 of 38 patients (26.5%).
Additional Outcomes
Studies reported several variables that improved
after supraglottoplasty (see Table V). Mase et al. reported
that the patients had increased postoperative weight for
length percentile.11 Li et al.,67 Oomen and Modi,10 and
Chan et al.2 reported that the patients had no stridor after
surgery. Li et al.67 and Chan et al.2 reported no feeding
difficulties postoperatively. With regard to levels of stridor
improvement, Zafereo et al.65 noted mild improvement in
10% of patients, significant improvement in 70%, and
complete resolution in 20%.
Complications
Digoy et al. reported that three of 36 children had a
postoperative increase in coughing and throat clearing,
and one had dysphagia for greater than 6 months.23
TABLE I.
General Characteristics and Quality Criteria of Included Studies.
Study’s General Characteristics Quality Assessment of Included Studies*
Year, Study Authors, Design
Study
Site Ages
Evidence
Level
Outcomes
Analyzed 1 2 3 4 5 6 7 8
2015, Mase et al.,11 RCS USA 17 mo (6–55) 4 AHI, MSAT, LSAT no yes yes yes no no yes yes
2015, Tholpady et al.,59 RCS USA NR 4 AHI no yes yes yes no no yes yes
2013, Li et al.,67 CC China 1–21 mo 3 LSAT no yes yes no no no yes no
2013, Oomen and Modi,10 RCR USA 5 mo 5 AHI, LSAT NA NA NA NA NA NA NA NA
2012, Chan (a) et al.,20 RCS USA 6.8 6 2.2 y 4 AHI, BMI, LSAT no yes yes yes no no yes yes
2012, Chan (b) et al.,2 RCS USA 7.1 y 4 AHI no yes yes yes no no yes yes
2012, Digoy et al.,23 RCS USA 1.2–12.6 y 4 AHI, LSAT no yes yes yes no yes yes yes
2011, Powitzky et al.,8 RCS USA NR 4 AHI, LSAT no no yes yes no no yes yes
2011, Revell and Clark,9 RCS USA < 11.1 y 4 AHI no yes yes no no no yes no
2009, O’Connor et al.,48 RCS Australia 2.3 mo (1–13) 4 AHI, LSAT no yes yes yes no no yes yes
2009, Sesterhenn et al.,57 RCS Germany 2.4 6 2.0 mo (1–7) 4 AHI, DI no yes no yes no no yes no
2008, Zafereo et al.,65 RCS USA 4 6 2.3 mo (1–9) 4 AHI, LSAT no yes yes yes no no yes yes
2006, Valera et al.,60 RCS Brazil 7.1 mo (1–17) 4 AHI, LSAT no no yes yes no no no yes
*Quality Assessment of cases series studies checklist from National Institute for Health and Clinical Excellence (NICE): 1) Was the case series collected
in more than one center (i.e., multicenter study)? 2) Is the hypothesis/aim/objective of the study clearly described? 3) Are the inclusion and exclusion criteria
(case definition) clearly reported? 4) Is there a clear definition of the outcomes reported? 5) Were data collected prospectively? 6) Is there an explicit statement
that patients were recruited consecutively? 7) Are the main findings of the study clearly described? 8) Are outcomes stratified? (e.g., by abnormal results, dis-
ease stage, patient characteristics)?
A.H.I. 5 Apnea-Hypopnea index; BMI 5 body mass index; CC 5 case-control; DI 5 Desaturation index; LSAT 5 lowest oxygen saturation; mo 5
months; MSAT 5 mean oxygen saturation; NA 5 Not applicable; NR 5 Not reported; RCR 5 retrospective case report; RCS 5 retrospective case series; y 5
years.
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Powitzky et al. reported that one of 20 patients required
a revision supraglottoplasty, whereas five required an
adenotonsillectomy to alleviate their OSA.8 O’Connor
et al. reported that during surgery, one patient devel-
oped a collapse of a pulmonary lobe on the left side due
to the endotracheal tube being in the right main bron-
chus.48 In the study by Sesterhenn et al., a revision epi-
glottopexy was performed for suture dehiscence, and
once the revision was performed the patient dramati-
cally improved.57 Four studies reported no significant or
major complications (see Table V).
DISCUSSION
There are five main findings from this study. First,
this review has demonstrated that sleep exclusive lar-
yngomalacia and congenital laryngomalacia have differ-
ent presentations and are comprised of distinct groups of
patients. In the currently published studies, all children
with sleep exclusive laryngomalacia have been diag-
nosed via drug-induced sleep endoscopy (DISE). Forty-
eight of 62 (77.4%) of the children in this systematic
review with sleep exclusive laryngomalacia were diag-
nosed after having failed adenotonsillectomy. Children
with sleep exclusive laryngomalacia are typically diag-
nosed at an older age (around 2–12 years), with a few
studies reporting the diagnosis in children under 2 years
of age. On the other hand, congenital laryngomalacia, as
the name implies, is identified soon after birth, and the
children will classically present with stridor and respira-
tory difficulty. In all studies evaluating congenital lar-
yngomalacia with OSA, flexible or awake laryngoscopy
was used for diagnosis, and DISE was additionally per-
formed in four of eight studies reporting supraglotto-
plasty outcomes.
Second, children with OSA and either sleep exclu-
sive laryngomalacia or congenital laryngomalacia can
have improvement in AHI after supraglottoplasty. In
children with sleep exclusive laryngomalacia and OSA,
supraglottoplasty decreased the AHI from a M 6 SD of
14.0 6 16.5 (95% CI 10.0, 18.0) to 3.3 6 4.0 (95% CI 2.4,
4.4), and when evaluating the SMD, the magnitude of
effect was large (Cohen’s guidelines), with a value of
20.99 (21.37, 20.62). In clinical practice, the diagnosis
of sleep exclusive laryngomalacia is made with DISE;
therefore, in children who fail adenotonsillectomy, DISE
could potentially help localize the site of obstruction (lin-
gual tonsils, epiglottis, arytenoids, etc.). In children with
congenital laryngomalacia and OSA, supraglottoplasty
decreased AHI from a M 6 SD of 20.4 6 23.9 (95% CI
12.8, 28.0) to 4.0 6 4.5 (95% CI 2.6, 5.4) events/hour,
and the SMD for congenital laryngomalcia was 21.26
(21.79, 20.73), which corresponds to a large effect.
Third, children with OSA and either sleep exclusive
laryngomalacia or congenital laryngomalacia can have
improvement in LSAT after supraglottoplasty. In chil-
dren with sleep exclusive laryngomalacia and OSA,
supraglottoplasty improved the LSAT from a M 6 SD of
84.8 6 8.4% (95% CI 82.8, 86.8) to 87.6 6 4.4% (95% CI
86.6, 88.8), and the SMD demonstrated a small magni-
tude of effect overall. Two studies did not demonstrate a
large improvement: the study by Chan (b)2 et al.
reported a 0.9 point increase in the LSAT in nine
patients, and Chan (a)20 et al. reported a 0.5 point
decrease in the LSAT in eight patients after supraglotto-
plasty—and why this occurred is unclear. For congenital
laryngomalacia, the LSAT improved from a M 6 SD of
74.5 6 11.9% (95% CI 70.9, 78.1) to 88.4 6 6.6% (95% CI
86.4, 90.4), with the SMD demonstrating a large magni-
tude of effect. The most dramatic improvement in LSAT
was reported in the study by Li et al.,67 who reported a
21.5 point improvement in LSAT after surgery, which is
likely secondary to the study specifically selecting
infants with severe laryngomalacia. Overall, supraglotto-
plasty improved the lowest oxygen saturation by 2.8
points in sleep exclusive laryngomalacia patients (Table
II) and by 13.9 points in congenital laryngomalacia
patients (Table III).
Fourth, when the subanalyses were performed by
using random effects modeling to evaluate if there was a
study or a group of studies that stood apart from the
rest as having better or worse than expected outcomes,
there was no study with significant differences for AHI
in sleep exclusive laryngomalacia and only one study
(O’Connor et al.48), with significant differences for AHI
in the congenital laryngomalacia patients. With regard
to the LSAT, there was statistically significant
TABLE II.
Sleep Exclusive Laryngomalacia.
Year, Study Authors N
Pre-SG
AHI
Post-SG
AHI
Pre-SG
Low O2
Post-SG
Low O2
2015, Mase et al.11 9 23.5 6 33.0 [1.9, 45.1] 4.8 6 3.5 [2.5, 7.1] 82.7 6 10.8 [75.6, 89.8] 88.3 6 3.5 [86.0, 90.6]
2013, Oomen and Modi10 1 10.2 2.4 88 89
2012, Chan (a) et al.20 8 12.4 6 11.8 [4.2, 20.6] 5.0 6 4.3 [2.0, 8.0] 89.8 6 4.7 [86.5, 93.1] 89.3 6 3.1 [87.1, 91.5]
2012, Chan (b) et al.2 9 10.4 6 8.8 [4.7, 16.2] 2.9 6 3.2 [0.8, 5.0] 89.0 6 4.0 [86.4, 91.6] 89.9 6 2.8 [88.1, 91.7]
2012, Digoy et al.23 36 13.3 6 12.9 [9.1, 17.5] 2.8 6 4.3 [1.4, 4.2] 83.0 6 8.6 [80.2, 85.8] 86.5 6 4.9 [84.9, 88.1]
2011, Revell and Clark9 1 2.5 0.3 - -
Total 64 14.0 6 16.5 [10.0, 18.0] 3.3 6 4.0 [2.4, 4.4] 84.8 6 8.4 [82.8, 86.8] 87.6 6 4.4 [86.6, 88.8]
Demographic and polysomnographic data pre- and postsupraglottoplasty.
[ ] denotes lower and upper 95% confidence intervals, - denotes not reported.
AHI 5 apnea-hypopnea index; low O2 5 lowest oxygen saturation; N 5 number; SG 5 supraglottoplasty.
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heterogeneity and low inconsistency for sleep exclusive
laryngomalacia studies and significant heterogeneity
and high inconsistency among the congenital laryngoma-
lacia studies. To find inconsistency and heterogeneity
with regard to the lowest oxygen saturation in this
meta-analysis is not surprising given that infants (i.e.,
Li et al.67) generally have worse oxygen desaturation
before surgery secondary to lower oxygen reserves as
compared to older children (Chan (a) et al.20 and Chan
(b) et al.).2 In children with congenital laryngomalacia,
the literature demonstrates the additional benefit of
improvement in daytime symptoms such as stridor, feed-
ing difficulties, and failure to thrive.
Fifth, additional research is needed. The earliest
study we identified reporting polysomnography outcomes
was by Marcus et al.47 in 1990; however, the study was
excluded because some of the patients were sedated with
chloral hydrate during the polysomnogram, and there
was no individual patient data for those not sedated. All
of the studies identified in the literature with quantita-
tive polysomnographic data meeting inclusion criteria
were published within the past decade. One study was
level 5 evidence (case report), 11 studies were level 4
(case series), and one study was level 3 (case-control);
there was no cohort and no randomized trial encoun-
tered in the literature. It should be pointed out that a
major confounder is that patients with the most severe
laryngomalacia may have significant obstruction (caus-
ing hypoxemia, cyanosis, acute life-threatening events,
cor pulmonale, pulmonary hypertension, etc.); these
patients generally undergo supraglottoplasty in a more
urgent fashion, and in that case there may not be pre-
and/or postoperative polysomnograms. Additionally, in
considering patients with severe symptoms, it may not
be possible to randomize them to either isolated supra-
glottoplasty or an observational control arm because the
lack of an intervention may be unacceptable and unethi-
cal due to the risk of allowing ongoing, untreated severe
obstructions, which can lead to repeated hypoxemia and
associated complications. Therefore, if randomized trials
were performed, they would likely include patients with
mild to moderate disease. Additionally, in order to facili-
tate the use of a common language, we are recommend-
ing that common terminology be used by researchers.
With regard to the type of patients included in the study,
it should be clear whether the patients are those with
congenital laryngomalacia, or if the patients are those
with sleep exclusive laryngomalacia. It would be
expected that patients with congenital laryngomalacia
will present earlier given that they generally have more
signs and symptoms than those who present when they
are older children. With regard to outcomes data, if the
TABLE III.
Congenital Laryngomalacia. Demographic and Polysomnographic Data Pre- and Post-Supraglottoplasty.
Year, Study Authors N
Pre-SG
AHI
Post-SG
AHI
Pre-SG
Low O2
Post-SG
Low O2
2015, Tholpady et al.59 3 12.0 6 1.9 [9.9, 14.2] 5.4 6 4.7 [0.1, 10.7] – –
2013, Li et al.67 16 – – 68.6 6 10.6 [63.4, 73.8] 90.1 6 4.1 [88.1, 92.1]
2011, Powitzky et al.8 20 11.2 (4.9, 16.2)* 4.7 (3.2, 8.5)* 84.5 (77.0, 89.9) 86.6 (82.0, 90.0)
2011, Revell and Clark9 2 9.6 6 4.9 [1.1, 13.3] 1.7 6 0.9 [0.1, 2.3] – –
2009, O’Connor et al.48 10 42.7 6 37.3 [19.6, 65.8] 4.5 6 4.8 [1.5, 7.5] 74.8 6 10.9 [68.0, 81.6] 87.6 6 4.0 [85.1, 90.1]
2009, Sesterhenn et al.57 8 15.6 6 7.6 [10.3, 20.9] 4.5 6 5.9 [0.4, 8.6] – –
2008, Zafereo et al.65 10 12.2 6 11.6 [5.0, 19.4] 4.2 6 4.8 [1.2, 7.2] 79.2 6 12.3 [71.6, 86.8] 87.4 6 11.1 [80.5, 94.3]
2006, Valera et al.60 5 9.5 6 6.2 [4.1, 14.9] 2.2 6 1.7 [0.7, 3.7] 83.2 6 9.7 [74.7, 91.7] 86.4 6 6.1 [81.1, 91.8]
Total† 74 20.4 6 23.9 [12.8, 28.0] 4.0 6 4.5 [2.6, 5.4] 74.5 6 11.9 [70.9, 78.1] 88.4 6 6.6 [86.4, 90.4]
*Denotes the median, with the 25th and 75th percentile values.
†Based on studies with means and standard deviations.
( ) denotes range; [ ] denotes lower and upper 95% confidence intervals; - denotes not reported; AHI 5 apnea-hypopnea index; low O2 5 lowest oxy-
gen saturation; N 5 number; SG 5 supraglottoplasty.
TABLE IV.
Meta-Analysis Data With Random Effects Modeling, Summarizing the Mean and Standardized Mean Differences With Magnitudes of Effect.
Variable MD MD 95% CI SMD SMD 95% CI Cohen’s Effect
Sleep exclusive laryngomalacia
AHI 29.38 [212.7, 26.10] 20.99 [21.37, 20.62] large
LSAT 1.79 [20.37, 3.96] 0.40 [0.04, 0.76] small
Congenital laryngomalacia
AHI 28.78 [212.40, 25.17] 21.26 [21.79, 20.73] large
LSAT 12.18 [4.02, 20.34] 1.31 [0.32, 2.30] large
95% CI 5 95% confidence interval; AHI 5 apnea-hypopnea index; Cohen’s effect 5 magnitude of effect based on Cohen’s guidelines; LSAT 5 lowest
oxygen saturation; MD 5 mean difference; SMD 5 standardized mean difference.
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following variables were reported consistently and in a
standardized fashion, it would significantly facilitate
future research: 1) polysomnography scoring criteria
used (e.g., 3% or 4% desaturations); 2) apnea-hypopnea
index should be reported, this would should not preclude
authors from reporting other indices (i.e., RDI); 3) oxy-
gen saturation variables, such as: a) the overall mean
oxygen saturation (M O2 sat), b) the oxygen desatura-
tion index, c) the time (T) spent below specific oxygen-
ation levels (i.e., 85% and 90% oxygen saturation [T <
85%] and [T < 90%], respectively), and d) lowest oxygen
saturation); 4) details regarding the extent of surgery
performed for the patients, with Ms and SDs; and 5)
publication of the individual patient data when possible.
Limitations
As with any systematic review, it is possible that
we missed studies in the literature despite our best
efforts. Second, there may be differences in hypopnea
scoring criteria between institutions; however, these dif-
ferences were not specified by the articles in this review.
Third, the studies were all retrospective in nature;
therefore, the study authors were limited to the data
available in the medical records.
CONCLUSION
Supraglottoplasty has improved AHI and LSAT in
children with OSA and either sleep exclusive laryngoma-
lacia or congenital laryngomalacia; however, the major-
ity of them are not cured.
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